BIOLINERX LTD-SPONS ADR (BLRX) Stock Balance Sheet
NASDAQ:BLRX • US09071M2052
Current stock price
2.4 USD
+0.07 (+3%)
Last:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 944.00K | 3.15M | 3.62M | 8.46M | |||
| Cash Equivalents | 7.91M | N/A | N/A | N/A | N/A | |||
| Marketable Securities | 17.30M | 18.62M | 39.84M | 47.46M | 48.67M | |||
| Receivables | 699.00K | 3.95M | 1.19M | 721.00K | 142.00K | |||
| Inventories | 2.18M | 3.15M | 1.95M | N/A | N/A | |||
| Other Current Assets | 432.00K | 443.00K | 1.05M | 198.00K | 127.00K | |||
| Total Current Assets | 28.52M | 27.10M | 47.18M | 52.00M | 57.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 892.00K | 1.35M | 1.89M | 2.50M | 2.28M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 10.39M | 10.45M | 14.85M | 21.89M | 21.70M | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 11.28M | 11.80M | 16.74M | 24.38M | 23.99M | |||
| TOTAL ASSETS | 39.80M | 38.91M | 63.92M | 76.38M | 81.39M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.78M | 5.00M | 3.67M | 1.97M | 2.92M | |||
| Accrued Expenses | N/A | 3.13M | 3.27M | 1.66M | 1.23M | |||
| Accounts Payable | 5.66M | 5.58M | 10.87M | 6.97M | 5.57M | |||
| Other Current Liabilities | 3.23M | 1.69M | 13.04M | 84.00K | 2.00K | |||
| Total Current Liabilities | 13.67M | 15.41M | 30.85M | 10.68M | 9.72M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.60M | 10.04M | 7.92M | 10.36M | 1.73M | |||
| Other Non-Current Liabilities | N/A | N/A | 11.93M | 4.51M | 1.86M | |||
| Total Non-Current Liabilities | 6.60M | 10.04M | 19.85M | 14.86M | 3.58M | |||
| TOTAL LIABILITIES | 20.27M | 25.45M | 50.70M | 25.54M | 13.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -379.74M | -376.91M | -372.20M | -313.82M | -290.91M | |||
| Additional Paid In Capital | 327.26M | 353.69M | 355.48M | 338.98M | 339.35M | |||
| Common Shares | 73.43M | 38.10M | 31.36M | 27.10M | 21.07M | |||
| Other Shareholders' Equity | -1.42M | -1.42M | -1.42M | -1.42M | -1.42M | |||
| Shares Outstanding | 3.73M | 1.91M | 1.55M | 1.32M | 1.02M | |||
| Tangible Book Value per Share | 0.00 | 0.00 | -0.00 | 0.03 | 0.06 | |||
| Total Shareholders' Equity | 19.53M | 13.46M | 13.22M | 50.84M | 68.09M | |||
| TOTAL LIABILITIES AND EQUITY | 39.80M | 38.91M | 63.92M | 76.38M | 81.39M | |||
| Statistics | ||||||||
| Debt/Equity | 0.34 | 0.75 | 0.60 | 0.20 | 0.03 | |||
| Current Ratio | 2.09 | 1.76 | 1.53 | 4.87 | 5.91 | |||
| Return On Assets (ROA) | -7.48% | -23.70% | -94.82% | -32.67% | -33.24% | |||
| Return On Equity (ROE) | -15.24% | -68.50% | -458.40% | -49.08% | -39.73% | |||
All data in USD , ROIC based on taxRate of 0.21